169 related articles for article (PubMed ID: 36044337)
1. MARVEL domain containing CMTM4 affects CXCR4 trafficking.
Bona A; Seifert M; Thünauer R; Zodel K; Frew IJ; Römer W; Walz G; Yakulov TA
Mol Biol Cell; 2022 Nov; 33(13):ar116. PubMed ID: 36044337
[TBL] [Abstract][Full Text] [Related]
2. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
Zhang T; Yu H; Dai X; Zhang X
Front Immunol; 2022; 13():971428. PubMed ID: 35958549
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma.
Tan S; Guo X; Bei C; Zhang H; Li D; Zhu X; Tan H
BMC Cancer; 2022 Aug; 22(1):905. PubMed ID: 35986302
[TBL] [Abstract][Full Text] [Related]
4. Gβ1 controls collective cell migration by regulating the protrusive activity of leader cells in the posterior lateral line primordium.
Xu H; Ye D; Behra M; Burgess S; Chen S; Lin F
Dev Biol; 2014 Jan; 385(2):316-27. PubMed ID: 24201188
[TBL] [Abstract][Full Text] [Related]
5. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
[TBL] [Abstract][Full Text] [Related]
6. The clinical and prognostic significance of CMTM6/PD-L1 in oncology.
Yaseen MM; Abuharfeil NM; Darmani H
Clin Transl Oncol; 2022 Aug; 24(8):1478-1491. PubMed ID: 35278198
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Chui NN; Cheu JW; Yuen VW; Chiu DK; Goh CC; Lee D; Zhang MS; Ng IO; Wong CC
Hepatol Commun; 2022 Jan; 6(1):178-193. PubMed ID: 34558800
[TBL] [Abstract][Full Text] [Related]
8. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.
Mezzadra R; Sun C; Jae LT; Gomez-Eerland R; de Vries E; Wu W; Logtenberg MEW; Slagter M; Rozeman EA; Hofland I; Broeks A; Horlings HM; Wessels LFA; Blank CU; Xiao Y; Heck AJR; Borst J; Brummelkamp TR; Schumacher TNM
Nature; 2017 Sep; 549(7670):106-110. PubMed ID: 28813410
[TBL] [Abstract][Full Text] [Related]
9. Essential requirement for zebrafish anosmin-1a in the migration of the posterior lateral line primordium.
Yanicostas C; Ernest S; Dayraud C; Petit C; Soussi-Yanicostas N
Dev Biol; 2008 Aug; 320(2):469-79. PubMed ID: 18585376
[TBL] [Abstract][Full Text] [Related]
10. CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.
Xue H; Li T; Wang P; Mo X; Zhang H; Ding S; Ma D; Lv W; Zhang J; Han W
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):915-924. PubMed ID: 31435638
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin Cd9b and Cxcl12a/Cxcr4b have a synergistic effect on the control of collective cell migration.
Marsay KS; Greaves S; Mahabaleshwar H; Ho CM; Roehl H; Monk PN; Carney TJ; Partridge LJ
PLoS One; 2021; 16(11):e0260372. PubMed ID: 34847198
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer.
Xue H; Qiu B; Wang H; Jiang P; Zhang W; Xue L; Wang J
Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1193-1196. PubMed ID: 35983975
[No Abstract] [Full Text] [Related]
13. Relationship between surrounding tissue morphology and directional collective migration of the posterior lateral line primordium in zebrafish.
Karaiwa A; Yamada S; Yamamoto H; Wakasa M; Ishijima H; Akiyama R; Hosokawa Y; Bessho Y; Matsui T
Genes Cells; 2020 Aug; 25(8):582-592. PubMed ID: 32516841
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.
Li M; Guo H; Wang Q; Chen K; Marko K; Tian X; Yang Y
Cancer Lett; 2020 Oct; 490():20-30. PubMed ID: 32585413
[TBL] [Abstract][Full Text] [Related]
15. CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.
Chrifi I; Louzao-Martinez L; Brandt MM; van Dijk CGM; Bürgisser PE; Zhu C; Kros JM; Verhaar MC; Duncker DJ; Cheng C
Angiogenesis; 2019 Feb; 22(1):75-93. PubMed ID: 30097810
[TBL] [Abstract][Full Text] [Related]
16. CMTM6 as a master regulator of PD-L1.
Yaseen MM; Abuharfeil NM; Darmani H
Cancer Immunol Immunother; 2022 Oct; 71(10):2325-2340. PubMed ID: 35294592
[TBL] [Abstract][Full Text] [Related]
17. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
19. Leading and trailing cells cooperate in collective migration of the zebrafish posterior lateral line primordium.
Dalle Nogare D; Somers K; Rao S; Matsuda M; Reichman-Fried M; Raz E; Chitnis AB
Development; 2014 Aug; 141(16):3188-96. PubMed ID: 25063456
[TBL] [Abstract][Full Text] [Related]
20. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
